Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;67(8):3268-3280.
doi: 10.1007/s12033-024-01255-x. Epub 2024 Aug 22.

Anoikis-Related Genes Impact Prognosis and Tumor Microenvironment in Bladder Cancer

Affiliations

Anoikis-Related Genes Impact Prognosis and Tumor Microenvironment in Bladder Cancer

Tao Zhang et al. Mol Biotechnol. 2025 Aug.

Abstract

Anoikis tolerance is an important biological process of tumor colonization and metastasis outside the primary tumor. Recent research has progressively elucidated the function and underlying mechanisms of anoikis in the metastasis of various solid tumors. Nevertheless, the specific mechanisms of anoikis in bladder cancer and its consequent effects on the tumor immune microenvironment remain ambiguous. In this study, we developed an anoikis score based on five genes (ETV7, NGF, SCD, LAMC1, and CASP6) and categorized subjects into high and low-risk groups using the median score from the TCGA database. Our findings indicate that SCD enhances the proliferation of bladder cancer cells in vitro. Furthermore, integrating the anoikis score with clinicopathological features to construct a prognostic nomogram demonstrated precision in assessing patient outcomes. Immune cell analysis revealed elevated infiltration levels of Treg cells and M2 macrophages in the high anoikis score group, whereas CD8+ T cell levels were reduced. This study highlights the importance of anoikis score in predicting patient prognosis, immune cell infiltration, and drug response, which may provide a treatment modality worth exploring in depth for the study of bladder cancer.

Keywords: Anoikis; Bladder cancer; Drug response; Immune microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: The authors declare that they have no conflicts of interest. Consent for Publication: Not applicable. Informed Consent: Informed consent was obtained from all subjects involved in the study.

Similar articles

References

    1. Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: Cancer Journal for Clinicians, 73(1), 17–48.
    1. Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., et al. (2016). Cancer statistics in China, 2015. CA: Cancer Journal for Clinicians, 66(2), 115–132.
    1. Jin, Y. H., Zeng, X. T., Liu, T. Z., Bai, Z. M., Dou, Z. L., Ding, D. G., et al. (2022). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline. Military Medical Research, 9(1), 44. - PubMed - PMC
    1. Jubber, I., Ong, S., Bukavina, L., Black, P. C., Compérat, E., Kamat, A. M., et al. (2023). Epidemiology of bladder cancer in 2023: A systematic review of risk factors. European Urology, 84(2), 176–190. - PubMed
    1. Liu, S., Chen, X., & Lin, T. (2021). Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy. Cancer Letters, 505, 13–23. - PubMed

LinkOut - more resources